Health & beauty
Clicks JSE: CLS
- Last price
- R210.09
- Today
- -1.83%
Delayed JSE price
Price and technicalsThe chart.
Clicks
Loading prices…
Company overviewIn plain words.
- 01What it sells
- Health and beauty through Clicks stores and pharmacies, plus pharmaceutical wholesale.
- 02How it makes money
- Front-shop beauty spend and dispensary traffic, backed by a big loyalty programme.
- 03What moves the share
- Store growth, pharmacy and beauty sales, and margins.
- Industry
- Pharmaceutical Retailers
- Head office
- Cape Town
- Financial year ends
- August
- Next results
- 22 Oct 2026
- Last ex-dividend date
- 01 Jul 2026
- Website
- clicksgroup.co.za ↗
FinancialsThe numbers, at a glance.
- Market value
- R48.7bn
- Price to earnings
- 14.9xForward 13.3x
- Dividend yield
- 4.2%
- Revenue
- R49.5bnlast 12 months
- Revenue growth
- +7.4%
- Earnings growth
- +8.3%
- Operating margin
- 9.1%
- Net margin
- 6.7%
- Return on equity
- 53.3%
- Debt to equity
- 72%
- Cash
- R1.2bnDebt R4.4bn
- Free cash flow
- R3.8bn
- R39.6bn2022
- R41.6bn2023
- R45.4bn2024
- R47.8bn2025
- R2.5bn2022
- R2.5bn2023
- R2.8bn2024
- R3.2bn2025
Headline numbers from Yahoo Finance, in rand, from the latest reported results. Growth compares with the same period a year earlier. Treat them as a sneak peek: read the company’s own results on SENS before relying on any of them.
What analysts sayThe sell-side view.
Consensus
Buy
7 analysts · average 2.4 on a 1 (strong buy) to 5 (strong sell) scale
43- Strong buy 0
- Buy 4
- Hold 3
- Sell 0
- Strong sell 0
Average 12-month target
R311.14
+48.1% vs today’s price
Target range
Low R235.00High R386.00
How the view has moved
- 3 months ago
- 2 months ago
- 1 month ago
- Now
Third-party ratings and price targets from sell-side analysts, as aggregated by Yahoo Finance. Yahoo does not name the analysts or firms behind JSE ratings, so we can’t either. This is what others say, not our view, and not advice.
In the newsRecent headlines.
Headlines from Moneyweb, BusinessTech, TechCentral, Daily Maverick, Bizcommunity and Marketaux, matched to companies by name automatically, so the odd one may be off. Not advice.
Also inHealth & beauty
All the shares we follow →Artive Capital doesn’t raise outside capital; it only trades and invests Artive’s own, and has no clients. Nothing on this page is advice or a recommendation to buy or sell. Prices are delayed and may be wrong; check with your broker before you act.
We don’t take outside money, but we always like talking markets and commerce.
For media, research and partnership questions, send us an email.